Literature DB >> 12415246

Therapeutic strategies for Alzheimer's disease.

Michael S Wolfe1.   

Abstract

Alzheimer's disease is a progressive and ultimately fatal neurological disorder for which there is no effective treatment at present. The disease is characterized pathologically by cerebral plaques that contain the amyloid-beta peptide and thread-like neuronal structures composed of the microtubule-associated protein TAU. Both amyloid-beta and TAU are thought to be crucial to pathogenesis, but compelling evidence supports amyloid-beta as the 'prime mover'. The main efforts for developing therapeutics are therefore focused on preventing amyloid-beta production, aggregation or downstream neurotoxic events. The progress of these and other approaches raises the hope that effective agents for the prevention and treatment of Alzheimer's disease will be available in the near future.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415246     DOI: 10.1038/nrd938

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  29 in total

Review 1.  Notch in the kidney: development and disease.

Authors:  Yasemin Sirin; Katalin Susztak
Journal:  J Pathol       Date:  2011-08-24       Impact factor: 7.996

2.  Nicastrin is required for amyloid precursor protein (APP) but not Notch processing, while anterior pharynx-defective 1 is dispensable for processing of both APP and Notch.

Authors:  Chen Hu; Linlin Zeng; Ting Li; Michael A Meyer; Mei-Zhen Cui; Xuemin Xu
Journal:  J Neurochem       Date:  2016-01-17       Impact factor: 5.372

Review 3.  Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

Authors:  Thuy Trang Nguyen; Tuong Kha Vo; Giau Van Vo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Computational simulations of the early steps of protein aggregation.

Authors:  Guanghong Wei; Normand Mousseau; Philippe Derreumaux
Journal:  Prion       Date:  2007-01-05       Impact factor: 3.931

Review 5.  Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

Authors:  Harald Hampel; Yong Shen; Dominic M Walsh; Paul Aisen; Les M Shaw; Henrik Zetterberg; John Q Trojanowski; Kaj Blennow
Journal:  Exp Neurol       Date:  2009-10-06       Impact factor: 5.330

Review 6.  Presenilins and the gamma-secretase: still a complex problem.

Authors:  David H Small; David W Klaver; Lisa Foa
Journal:  Mol Brain       Date:  2010-02-05       Impact factor: 4.041

7.  Effect of chirality of small molecule organofluorine inhibitors of amyloid self-assembly on inhibitor potency.

Authors:  Abha Sood; Mohammed Abid; Samson Hailemichael; Michelle Foster; Béla Török; Marianna Török
Journal:  Bioorg Med Chem Lett       Date:  2009-10-21       Impact factor: 2.823

Review 8.  The pathogenic role of Notch activation in podocytes.

Authors:  Thiruvur Niranjan; Mariana Murea; Katalin Susztak
Journal:  Nephron Exp Nephrol       Date:  2009-03-17

Review 9.  Novel approaches to models of Alzheimer's disease pathology for drug screening and development.

Authors:  Laura Shaughnessy; Beth Chamblin; Lori McMahon; Ayyappan Nair; Mary Beth Thomas; John Wakefield; Frank Koentgen; Ram Ramabhadran
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Current therapeutic options for Alzheimer's disease.

Authors:  Alberto Lleó
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.